Correlation Between Sonnet Biotherapeutics and Enveric Biosciences
Can any of the company-specific risk be diversified away by investing in both Sonnet Biotherapeutics and Enveric Biosciences at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Sonnet Biotherapeutics and Enveric Biosciences into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Sonnet Biotherapeutics Holdings and Enveric Biosciences, you can compare the effects of market volatilities on Sonnet Biotherapeutics and Enveric Biosciences and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Sonnet Biotherapeutics with a short position of Enveric Biosciences. Check out your portfolio center. Please also check ongoing floating volatility patterns of Sonnet Biotherapeutics and Enveric Biosciences.
Diversification Opportunities for Sonnet Biotherapeutics and Enveric Biosciences
0.63 | Correlation Coefficient |
Poor diversification
The 3 months correlation between Sonnet and Enveric is 0.63. Overlapping area represents the amount of risk that can be diversified away by holding Sonnet Biotherapeutics Holding and Enveric Biosciences in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Enveric Biosciences and Sonnet Biotherapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Sonnet Biotherapeutics Holdings are associated (or correlated) with Enveric Biosciences. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Enveric Biosciences has no effect on the direction of Sonnet Biotherapeutics i.e., Sonnet Biotherapeutics and Enveric Biosciences go up and down completely randomly.
Pair Corralation between Sonnet Biotherapeutics and Enveric Biosciences
Given the investment horizon of 90 days Sonnet Biotherapeutics Holdings is expected to under-perform the Enveric Biosciences. In addition to that, Sonnet Biotherapeutics is 1.38 times more volatile than Enveric Biosciences. It trades about -0.55 of its total potential returns per unit of risk. Enveric Biosciences is currently generating about -0.46 per unit of volatility. If you would invest 50.00 in Enveric Biosciences on August 26, 2024 and sell it today you would lose (17.00) from holding Enveric Biosciences or give up 34.0% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Significant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Sonnet Biotherapeutics Holding vs. Enveric Biosciences
Performance |
| Timeline |
| Sonnet Biotherapeutics |
| Enveric Biosciences |
Sonnet Biotherapeutics and Enveric Biosciences Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Sonnet Biotherapeutics and Enveric Biosciences
The main advantage of trading using opposite Sonnet Biotherapeutics and Enveric Biosciences positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Sonnet Biotherapeutics position performs unexpectedly, Enveric Biosciences can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Enveric Biosciences will offset losses from the drop in Enveric Biosciences' long position.| Sonnet Biotherapeutics vs. Eliem Therapeutics | Sonnet Biotherapeutics vs. HCW Biologics | Sonnet Biotherapeutics vs. Scpharmaceuticals | Sonnet Biotherapeutics vs. Milestone Pharmaceuticals |
| Enveric Biosciences vs. Ocean Biomedical | Enveric Biosciences vs. Hepion Pharmaceuticals | Enveric Biosciences vs. Elevation Oncology | Enveric Biosciences vs. Zura Bio Limited |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Manager module to state of the art Portfolio Manager to monitor and improve performance of your invested capital.
Other Complementary Tools
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
| CEOs Directory Screen CEOs from public companies around the world | |
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
| Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges |